Order Article Reprints

Fasanaro E, Del Bianco P, Groff E, Riva A, Petrangolini G, Busato F, Stritoni P, Scarzello G, Loreggian L, De Salvo GL. Role of SAMITAL in the Prevention and Treatment of Chemo-Radiotherapy-Induced Oral Mucositis in Head and Neck Carcinoma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (ROSAM). Cancers. 2022; 14(24):6192. https://doi.org/10.3390/cancers14246192

Fasanaro, Elena, Paola Del Bianco, Elena Groff, Antonella Riva, Giovanna Petrangolini, Fabio Busato, Paola Stritoni, Giovanni Scarzello, Lucio Loreggian, and Gian Luca De Salvo. 2022. "Role of SAMITAL in the Prevention and Treatment of Chemo-Radiotherapy-Induced Oral Mucositis in Head and Neck Carcinoma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (ROSAM)" Cancers 14, no. 24: 6192. https://doi.org/10.3390/cancers14246192

Fasanaro, E., Del Bianco, P., Groff, E., Riva, A., Petrangolini, G., Busato, F., Stritoni, P., Scarzello, G., Loreggian, L., & De Salvo, G. L. (2022). Role of SAMITAL in the Prevention and Treatment of Chemo-Radiotherapy-Induced Oral Mucositis in Head and Neck Carcinoma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (ROSAM). Cancers, 14(24), 6192. https://doi.org/10.3390/cancers14246192